Beijing Tiantan Hospital: Stroke trials

The registry lists 52 Stroke studies with Beijing Tiantan Hospital as lead sponsor. 23 are open to participants now and 0 have results posted.

Phase 2 15Phase 3 16Phase 4 2No phase 21(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain TumorNot yet recruitingNCT07520370Not applicable
• Advancing Reperfusion Therapy for Ischemic Stroke: Safety and Efficacy of Anakinra for Futile Reperfusion Following Endovascular Treatment in Patients With Acute Ischemic StrokeRecruitingNCT07423975Phase 2
• Observational RegIstry of Effectiveness and Safety of teNecTeplase in reAl worLd Settings in ChinaRecruitingNCT07271342
• Y-6 Sublingual Tablets for Patients With Acute Ischemic StrokeNot yet recruitingNCT07040085Phase 3
• Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)Not yet recruitingNCT07035405Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYONDRecruitingNCT06954155Phase 3
• Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm ClippingRecruitingNCT06819657Not applicable
• Effect of Acetaminophen on Neurological Outcome in Acute Ischemic Stroke Patients Undergoing Endovascular TreatmentNot yet recruitingNCT06767969Not applicable
• Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid HemorrhageNot yet recruitingNCT06711302Not applicable
• The Androtriol Injection for the Treatment of Acute Ischemic StrokeNot yet recruitingNCT06679322Phase 2
• Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and PuerperiumRecruitingNCT06527807
• Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D )RecruitingNCT06522282Phase 3
• Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）RecruitingNCT06319846Phase 3
• GD-11 for Injection in the Treatment of Acute Ischemic StrokeRecruitingNCT06299579Phase 3
• Oxygen Concentration Target in Stroke Endovascular TreatmentRecruitingNCT06224426Not applicable
• EFfects of Y-6 SUblingual Tablets foR PaTients With AcUte Ischemic StRokE (FUTURE)Not yet recruitingNCT06138834Phase 2
• A Registry Study of Microcirculation Disorder After Cerebral Small Vessel Disease and Ischemic StrokeNot yet recruitingNCT06077305
• Cilostazol Dexborneol Versus Placebo for Microcirculation Dysfunction After Reperfusion Therapy in Patients With Acute Ischemic Stroke With Large Vessel OcclusionRecruitingNCT05836766Phase 2
• Efficacy and Safety of Sarecycline in Patients With Acute Ischemic Stroke After Reperfusion TherapyRecruitingNCT05836753Phase 2
• Cerebral Autoregulation Guiding Blood Pressure Management After RevascularizationNot yet recruitingNCT05670028Phase 2
• Intra-arterial Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for Acute Large Vascular Occlusion After Successful Mechanical Thrombectomy RecanalizationRecruitingNCT05624190Phase 4
• REperfusion Therapy for Acute Ischemic STrOke Due to Large aRtEry OcclusionRecruitingNCT05311605
• Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease TrialRecruitingNCT04948749Not applicable
• Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-A )CompletedNCT06492239Phase 2
• Y-3 Injection in the Treatment of Acute Ischemic Stroke Phase II Clinical TrialCompletedNCT06429384Phase 2
• Low-Frequency REpetitive TRanscranial Magnetic Stimulation in ACute Ischemic StrokE Within 48 HoursCompletedNCT06064734Not applicable
• Y-3 Injection Through Skull Bone Marrow in the Treatment of Acute Malignant Middle Cerebral Artery Infarction (SOLUTION)CompletedNCT05849805Not applicable
• Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic StrokeCompletedNCT05836740Phase 3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ）Status unknownNCT05745259Phase 3
• Tenecteplase REperfusion in Acute Ischemic sTroke Registry（TREAT）Status unknownNCT05724342
• Evaluating the Safety and Efficacy of the Maurora® DES in ICASCompletedNCT05719883Not applicable
• Dengzhanxixin Injection for Acute Ischemic Stroke Receiving Reperfusion TherapyStatus unknownNCT05700097Phase 2
• Colchicine in High-risk Patients With Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3)CompletedNCT05439356Phase 3
• PROpranolol for Cerebral Hemorrhage-ASsociated pnEumonia (PRO-CHASE)CompletedNCT05419193Phase 2/3
• Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-II）Status unknownNCT05281549Phase 2
• Treatment of Acute Ischemic STroke With Edaravone Dexborneol II (TASTE-2)CompletedNCT05249920Phase 3
• Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-IIICompletedNCT05141305Phase 3
• Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)CompletedNCT04676659Phase 2
• An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)Status unknownNCT04524624Not applicable
• Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of OnsetCompletedNCT04486430Phase 2
• Genetic Identification of Monogenic Disorders in Early-onset Stroke Using Targeted Next Generation Sequencing PanelCompletedNCT04485598
• The Effectiveness of Rehabilitation Training Based on Brain-computer Interface Technology to Improve the Upper Limb Motor Function of Ischemic Stroke.CompletedNCT04387474Not applicable
• INdobufen Versus aSpirin in acUte Ischemic stRokE,INSURECompletedNCT03871517Phase 4
• Intensive Medical Therapy for High-risk Intracranial or Extracranial AtherosclerosisActive, not recruitingNCT03635749Phase 3
• Improve Acute Reperfusion Treatment Quality for Stroke in China, IMPROVE: Stroke Care in ChinaCompletedNCT03578107Not applicable
• Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular TreatmentCompletedNCT03539445Phase 3
• A Prospective Cohort Study of Perioperative Covert Stroke and Postoperative Cognitive DysfunctionCompletedNCT03081429
• Impact of Anesthesia Type on Outcome in Patients With Acute Ischemic Stroke (AIS) Undergoing Endovascular TreatmentStatus unknownNCT02677415Not applicable
• A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.CompletedNCT02526225Phase 2
• Platelet Reactivity in Acute Non-disabling Cerebrovascular EventsCompletedNCT02506140Phase 2/3
• Intervention to Bridge the Evidence-based Gap in Stroke Care QualityCompletedNCT02212912Not applicable
• Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular EventsCompletedNCT00979589Phase 3